Search

Author/Creator Strand, V

32. SAT0182 Sirukumab leads to significant and clinically meaningful improvements in health-related quality of life that meet or exceed normative values in patients with rheumatoid arthritis refractory to tnf inhibitors in post hoc analyses of a phase 3 trial. (15th June 2017)

Authors:
Strand, V; Ganguly, R; Li, N; McQuarrie, K
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
839
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

33. SAT0217 Early patient-reported outcomes and clinical outcomes with abt-494 in patients with active rheumatoid arthritis who are inadequate responders to methotrexate or tumor necrosis factor inhibitors: post-hoc analysis of phase 2 randomized controlled trials. (15th June 2017)

Authors:
Strand, V; Tundia, N; Song, IH; Meerwein, S; Lin, J; Chen, N; Friedman, A
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
855
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

34. SAT0468 Presence of poor prognostic factors may predict response to abatacept in patients with active psoriatic arthritis: results from a post hoc analysis from a phase iii study. (15th June 2017)

Authors:
Mease, P; McInnes, I; Strand, V; FitzGerald, O; Ahmad, H; Johnsen, A; Ye, J; Banerjee, S
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
951
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

35. SAT0480 Comparative effectiveness of secukinumab and infliximab in psoriatic arthritis assessed by matching-adjusted indirect comparison using pivotal phase 3 clinical trial data. (15th June 2017)

Authors:
Strand, V; McInnes, I; Mease, P; Choy, E; Nash, P; Thom, H; Kalyvas, C; Gandhi, K; Pricop, L; Jugl, S
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
957
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

39. THU0393 Secukinumab provides sustained reduction in fatigue in patients with ankylosing spondylitis through 3 years: long-term results of two randomised double-blind placebo-controlled phase 3 studies. (15th June 2017)

Authors:
Kvien, TK; Deodhar, A; Gossec, L; Conaghan, PG; Strand, V; Østergaard, M; Williams, N; Porter, B; Gandhi, K; Jugl, S
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
355
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

40. THU0677 Outcome measurement instruments for safety in rheumatology: a scoping review of available instruments to inform the omeract safety working group. (15th June 2017)

Authors:
Klokker, L; Woodworth, T; Furst, DE; Tugwell, P; Devoe, D; Williamson, P; Terwee, CB; Suarez-Almazor, ME; Strand, V; Leong, AL; Goel, N; Boers, M; Brooks, PM; Simon, LS; Christensen, R
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
463
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗